The standard antitubercular treatment (ATT), which consists of isoniazid (INH), rifampicin (RIF), ethambutol, and pyrazinamide (PZA), is the best available treatment for tuberculosis (TB). However, the hepatotoxicity of INH and PZA can be severe, and even after drug withdrawal, patients may require
Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery
✍ Scribed by Luiz Augusto Carneiro D'Albuquerque; Adriano Miziara Gonzalez; Raul Carlos Wahle; Evandro de Oliveira Souza; Jorge Marcelo Padilla Mancero; Adávio de Oliveira e Silva
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 194 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21472
No coin nor oath required. For personal study only.
✦ Synopsis
New therapeutic options for obesity include restrictive bowel surgery and surgery that promotes malabsorption, such as the Fobi-Capella (gastric bypass) and Scopinaro (biliopancreatic diversion) techniques. Complications associated with these procedures, such as hepatocellular failure, have been observed with increasing frequency. Reported here are 3 patients who, 7 to 24 months after bariatric surgery, developed hepatocellular failure, for which liver transplantation was considered to be indicated. Liver transplantation was undertaken in 2 of the patients; the third patient died while waiting for this procedure. We discuss the possible causes of this uncommon and poorly understood complication of surgery for obesity. One possibility is that it might arise as a result of progression of steatohepatitis. An alternative concept is that this complication may be secondary to rapid, massive loss of body weight.
📜 SIMILAR VOLUMES